standard]
MKISKLRVLPLMTVLFLCHAFVEAEDMNNQQKKKIFIIHMDKSNMPASFD
DHLQWYDSSLKSVSDSANMLYIYNNVIHGYSVQLTAEEAGFLKEQPGILL
VQEDIKYELHTTRSPEFLGLLNSDAYLPESSTPSEVIIGVVDTGVWPEAS
SFDDKGLGPLPNGWKGECEVGRTFNSSSCNRKLIGARFFSEGYEAAFGPI
DETAESKSPRDDDGHGTHTSTTAAGSTVVGASLFGYAAGSLSNVAPWITT
VGAGTMDRQFPAYVTLGNGKKLTGASVYSGKSLAGSLMPLVYARNVSSTS
NGNLCTKGSLIPEKVKGKIVVCDRGMNPRAQKSLEVKDAGGIGMVLSNTD
AFGEELVADAHFIPTAAVGQIAGDEIKKYILSEPNPSATIASAGTQLGVQ
PSPVVAAFSSRGPNPITPDILKPDLIAPGVNILAGWTGKVGPTGLPEDTR
HVDFNIISGTSMSCPHVSGLAALVKAAHPEWSPAAIRSALMTTAYSKYKN
GERIQDVATGMASTPFDHGAGHVDPVSALDPGLVYDITVEDYLNFLCAIK
YSSSMIKIITKQDYSCKVDKEYSVAGLNYPSFAVPLQTASGPNGGSSAPT
TVKYTRTLTNVGNPATYKVTISQETEAVKILVLPEVLDFSNPNEKKTYTV
KFTARSMPSGTTSYAHLEWSDGKHIVGSPIVFSWT
|
IPR000209; Peptidase S8/S53, subtilisin/kexin/sedolisin IPR003137; Protease-associated domain, PA IPR010259; Proteinase inhibitor I9, subtilisin propeptide IPR022398; Peptidase S8/S53, subtilisin, act |